Scinovex
reviewTop 1% cited

Is dehydroepiandrosterone a hormone?

Journal of Endocrinology · 2005 · Vol. 187(2) · pp. 169–196
Fernand LabrieVan Luu‐TheA. BèlangerSheng‐Xiang LinJacques SimardG. PelletierClaude Labrie

Abstract

Dehydroepiandrosterone (DHEA) is not a hormone but it is a very important prohormone secreted in large amounts by the adrenals in humans and other primates, but not in lower species. It is secreted in larger quantities than cortisol and is present in the blood at concentrations only second to cholesterol. All the enzymes required to transform DHEA into androgens and/or estrogens are expressed in a cell-specific manner in a large series of peripheral target tissues, thus permitting all androgen-sensitive and estrogen-sensitive tissues to make locally and control the intracellular levels of sex steroids according to local needs. This new field of endocrinology has been called intracrinology. In women, after menopause, all estrogens and almost all androgens are made locally in peripheral tissues from DHEA which indirectly exerts effects, among others, on bone formation, adiposity, muscle, insulin and glucose metabolism, skin, libido and well-being. In men, where the secretion of androgens by the testicles continues for life, the contribution of DHEA to androgens has been best evaluated in the prostate where about 50% of androgens are made locally from DHEA. Such knowledge has led to the development of combined androgen blockade (CAB), a treatment which adds a pure anti-androgen to medical (GnRH agonist) or surgical castration in order to block the access of the androgens made locally to the androgen receptor. In fact, CAB has been the first treatment demonstrated to prolong life in advanced prostate cancer while recent data indicate that it can permit long-term control and probably cure in at least 90% of cases of localized prostate cancer. The new field of intracrinology or local formation of sex steroids from DHEA in target tissues has permitted major advances in the treatment of the two most frequent cancers, namely breast and prostate cancer, while its potential use as a physiological HRT could well provide a physiological balance of androgens and estrogens, thus offering exciting possibilities for women's health at menopause.

Hormonal and reproductive studiesProstate Cancer Treatment and ResearchSexual Differentiation and DisordersEndocrinologyInternal medicineDehydroepiandrosteroneAndrogenIntracrineLibidoAndrogen receptorAndrostenediolTestosterone (patch)Estrogen

MeSH terms

AdultAgedAndrogen AntagonistsAnimalsBreastBreast NeoplasmsCastrationDehydroepiandrosteroneFemaleHumansMaleMiddle AgedProstateProstatic NeoplasmsGonadal Steroid Hormones
Citations
450
FWCI
13.21
field-weighted impact
References
276
Percentile
99%
vs. same field & year
Citations per year
Cited by
References
Cancer Statistics, 2005
CA A Cancer Journal for Clinicians · 2005 · 5,459 citations
Age Changes and Sex Differences in Serum Dehydroepiandrosterone Sulfate Concentrations throughout Adulthood
The Journal of Clinical Endocrinology & Metabolism · 1984 · 1,361 citations
Hormone Therapy To Prevent Disease and Prolong Life in Postmenopausal Women
Annals of Internal Medicine · 1992 · 2,359 citations
Sexual Dysfunction in the United States
JAMA · 1999 · 5,088 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.